Pancreatic Cancer Research

ResearcherCardiff UniversityNo recent work listed

Shuo Cai

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5102354015. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression. Co-author DOI 10.3892/ijo.2021.5214↗
  2. Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression. Co-author DOI 10.3892/ijo.2017.3953↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lin Ye · 2 shared papers, 2017–2021 · strength 0.17
  2. Chunyi Hao · 2 shared papers, 2017–2021 · strength 0.17
  3. Wen G. Jiang · 2 shared papers, 2017–2021 · strength 0.17
  4. Bilal A. Al-Sarireh · 2 shared papers, 2017–2021 · strength 0.17
  5. Jiafu Ji · 1 shared paper, 2021 · strength 0.11
  6. Gang Chen · 1 shared paper, 2017 · strength 0.06
  7. Ying Liu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.